Merit Award

The Merit Award is open to oncology trainees who are first authors on abstracts selected for presentation at an ASCO scientific meeting, including the ASCO Annual Meeting or smaller thematic meetings.

Based on funding availability at the time of the Award, a limited number of Merit Awards will be awarded to fellows and residents whose research is addressed in high-quality abstracts submitted to an ASCO Meeting and recognized for its scientific merit. Recipients of Merit Awards are honored with the opportunity to present their abstract at the Annual Meeting and ASCO thematic meetings and to receive $1,000 in monetary support, complimentary registration for the ASCO Meeting and access to reserved Meeting housing. Merit Award candidates must apply for the award at the time of abstract submission

Eligibility

Applicants (first author) must meet the following criteria to be considered for an Annual Meeting Merit Award:

  • Hold a doctoral degree (including but not limited to MD, DO, PharmD, or PhD) or be a doctoral degree candidate at the time of abstract submission
  • Be enrolled in an oncology fellowship training program or equivalent training program at the time of abstract submission
  • Work in an oncology laboratory or clinical research setting
  • Agree to present the abstract at the Annual Meeting
  • Provide a letter of support from his or her Training Program Director, indicating eligibility for the award
  • Provide a two-page curriculum vitae

Merit Awards are also given for the following meetings subject to the availability of funding:

  • ASCO Annual Meeting
  • ASCO-SITC Clinical Immuno-Oncology Symposium
  • Cancer Survivorship Symposium
  • Gastrointestinal Cancers Symposium
  • Genitourinary Cancers Symposium
  • Molecular Markers in Cancer Meeting
  • Palliative Care in Oncology Symposium
  • Quality Care Symposium

 

Special Merit Awards

Special Merit Awards are presented to trainees and junior faculty who have the top-ranking abstracts for the ASCO Annual Meeting. In addition to the stipend, recipients receive a plaque and are recognized at the ASCO Annual Meeting.

Bradley Stuart Beller Special Merit Award ($2,000)

This award is given to the fellow who has the highest ranking abstract overall in the Merit Award category as determined by the Scientific Program Committee. The award is funded through the Bradley Stuart Beller Endowment Fund.

Brigid Leventhal Special Merit Award 

This award is given to the fellow who submitted the top abstract in Pediatric Oncology as determined by the Scientific Program Committee.

Pain Special Merit Award

This award is given to the fellow who submitted the top abstract in Pain and Symptom Management Research as determined by the Scientific Program Committee.

Allen S. Lichter, MD Endowed Merit Award

This award was established by the Conquer Cancer Foundation in 2016 to recognize Dr. Allen S. Lichter (CEO of ASCO and CCF, 2006-2016), his leadership and his meritorious contributions to advancing cancer research, education, quality of care, and global oncology. The award is given to a fellow who submitted a high-ranking abstract as determined by the Scientific Program Committee.

James B. Nachman ASCO Junior Faculty Award in Pediatric Oncology ($3,000)

This award was established in memory of James B. Nachman, MD, Professor of Pediatrics at the University of Chicago and an internationally renowned pediatric cancer expert. It is endowed through the James B. Nachman Pediatric Oncology Fund and will be given each year to a junior faculty member who submits the highest ranking abstract in pediatric oncology for the ASCO Annual Meeting as determined by the ASCO Scientific Program Committee. The recipient will receive $3,000 in monetary support to attend the Annual Meeting, complimentary registration for the Annual meeting and access to reserved Meeting housing. Candidates must apply for this award at the time of abstract submission.

The First Author must meet all of the following requirements to be considered for the James B. Nachman ASCO Junior Faculty Award in Pediatric Oncology:

  • Hold a medical or doctoral degree (MD, PhD, DO, or DNP)
  • Be within 7 years of their first faculty appointment at the time of abstract submission
  • Conduct laboratory, population-based, or clinical research focused on childhood cancer
  • Agree to present the abstract at the ASCO Annual Meeting
  • In addition, the abstract must be selected for presentation in an Oral Abstract Session

Application Instructions

Consideration for a Merit Award is available on the abstract submitter for the ASCO Annual Meeting and other ASCO thematic meetings.

Abstract Submission Deadlines:

2017 Cancer Survivorship Symposium: October 4, 2016 at 11:59 PM EDT (Closed)
2017 ASCO-SITC Clinical Immuno-Oncology Symposium: October 18th, 2016 at 11:59 PM EST (Closed)
2017 Genitourinary Cancers Symposium: October 25th, 2016 at 11:59 PM EST
2017 Quality Care Symposium: November 8, 2016 at 11:59 PM EST
2017 Annual Meeting: February 7, 2017 at 11:59 PM EST

2016 Annual Meeting Merit Award Recipients

Mohammad Abu Zaid, MBBS
Indiana University
Sally Adebamowo, MD, MSc, ScD
National Institutes of Health
Nabil Adra, MD
Indiana University
Anosheh Afghahi, MD, MPH
Stanford University
Carlotta Antoniotti, MD
Universitaria Pisana, Italy
Suresh Kumar Balasubramanian, MD
Cleveland Clinic Foundation
Martin Berger, MD
University of Southern California
Maria Carlo, MD
Memorial Sloan Kettering Cancer Center
Tina Cascone, MD
The University of Texas M.D. Anderson Cancer Center
Richard Cassidy, MD
Winship Cancer Institute, Emory University
Jacob Chabon
Stanford University
Kezhong Chen, MD
Peking University People's Hospital, China
Melvin Chua, MBBS, FRCR, PhD
Princess Margaret Hospital, Canada
Andrea Covelli, MD, PhD
University of Toronto, Canada
Gwen Dackus, MD
Netherlands Cancer Institute
Tom Degenhardt
University of Munich, Germany
Saoirse Dolly, BSc, MBBS, MRCP, PhD
The Royal Marsden Hospital, United Kingdom
Maryam Doroudi, PhD
National Cancer Institute, National Institutes of Health
Narendranath Epperla, MD
Medical College of Wisconsin
David Falchook, MD
The University of North Carolina, Chapel Hill
Daniel Farrugia, MD PhD
The University of Pittsburgh
Caterina Fontanella, MD
University Hospital, Italy
Claire Friedman, MD
Memorial Sloan Kettering Cancer Center
Samuel Funt, MD
Memorial Sloan Kettering Cancer Center
Karuna Ganesh, MD, PhD
Memorial Sloan Kettering Cancer Center
Mark Geyer, MD
Memorial Sloan Kettering Cancer Center
Oleg Gluz, MD
West German Study Group, Germany
Noa Gordon, MSc, MPH
Rabin Medical Center, Israel
Sangeeta Goswami, MD, PhD
The University of Texas M.D. Anderson Cancer Center
Katie Greenzang, MD, EdM
Dana-Farber Cancer Institute
Roman Groisberg, MD
The University of Texas M.D. Anderson Cancer Center
Tami Grunewald, MBBS
Prince of Wales Hospital, Australia
Arjun Gupta, MD
The University of Texas Southwestern Medical Center
Jean Hansen, DO
University of Texas M.D. Anderson Cancer Center
Samuel Harris, MBBS FRACP
The Royal Marsden Hospital, United Kingdom
Shaodong Hong, MD
Sun Yat-sen University, China
Ali Hosni, MBBCh, MSc
Princess Margaret Cancer Centre, Canada
Jeff Hosry, MD
The University of Texas M.D. Anderson Cancer Center
Bei Hu, MD
The University of Texas M.D. Anderson Cancer Center
Kosuke Kawaguchi, MD
Kyoto University, Japan
Kenneth Kehl, MD
The University of Texas M.D. Anderson Cancer Center
Monica Khunger, MD
Cleveland Clinic Foundation
Shigehiro Koganemaru, MD
Toranomon Hospital, Japan
Catherine Labbe, MD
Princess Margaret Cancer Centre, Canada
Mariette Labots, MD
Vanderbilt University
Angela Lamarca, MD, PhD
The Christie NHS Foundation Trust, United Kingdom
Pernelle Lavaud
Institut Gustave Roussy, France
George Lee, PhD
Case Western Reserve University
Yeh Chen Lee, MBBS
Peter MacCallum Cancer Centre, Australia
Jonathan Leeman, MD
Memorial Sloan Kettering Cancer Center
Jeremy Lewin, MBBS FRACP
Princess Margaret Cancer Centre, Canada
David Liu, MD, MS, MPH
Dana-Farber Cancer Institute
Kah Poh Loh, MBBCh
University of Rochester
Go Makimoto, MD
Okayama University , Japan
Jennifer McQuade, MD
The University of Texas M.D. Anderson Cancer Center
Robert Meehan, MD
National Cancer Institute, National Institutes of Health
Niven Mehra, MD, PhD
The Royal Marsden Hospital, United Kingdom
Soizick Mesnage, MbChB, MSc
Institut Gustave Roussy, France
Dominik Modest, MD
University of Munich, Germany
Moaath Mustafa Ali, MD
Cleveland Clinic Foundation
Maryam Nemati Shafaee, MD
The University of Texas M.D. Anderson Cancer Center
Terence Ng, BSc.(Pharm) Hons
National University of Singapore
Geraldine O'Sullivan Coyne, MD., Ph.D.
National Cancer Institute, National Institutes of Health
Patience Odele, MD
Northwestern University
David Oh, MD, PhD
The University of California San Francisco
Travis Osterman, DO
Vanderbilt University
Emanuela Palmerini, MD
Istituto Ortopedico Rizzoli, Italy
Jonas Paludo, MD
Mayo Clinic
Manali Patel, MD, MPH
Stanford University
Sagar Patel, MD
Cleveland Clinic Foundation
Anh Pham, MD
City of Hope National Medical Center
David Pinato, MD, MRes, PhD, MRCP
Imperial College London, United Kingdom
Amy Prawira, MBBS, Bmedsc
Princess Margaret Cancer Centre, Canada
Praful Ravi, MBBChir
Mayo Clinic
Matthew Reilley, MD
The Univeristy of Texas M.D Anderson Cancer Center
Damian Rieke, MD
Charité Comprehensive Cancer Center, Germany
Matthew Rioth, MD
Vanderbilt University
Felicia Roncolato, MBChB, FRACP
St. George Hospital, New Zealand
Jose Ruiz Morales, MD
University of Calgary, Canada
Rachel Sanford, MD
The University of Texas M.D. Anderson Cancer Center
Marta Schirripa, MD
University of Southern California
Shiraj Sen, MD, PhD
The University of Texas M.D. Anderson Cancer Center
Elizabeth Smyth, MD
The Royal Marsden Hospital, United Kingdom
Lillian Smyth, MD
Memorial Sloan Kettering Cancer Center
Jacob Soumerai, MD
Memorial Sloan Kettering Cancer Center
Samer Srour, MB ChB, MS
The University of Texas M.D. Anderson Cancer Center
Ishwaria Subbiah, MD, MS
The University of Texas M.D. Anderson Cancer Center
Mitsukuni Suenaga, MD, PhD
University of Southern California
Vineeth Sukrithan, MD
Albert Einstein Cancer Center
Paul Swiecicki, MD
University of Michigan
Nidhi Tandon, MD, MBBS
Mayo Clinic
Chad Tang, MD
The University of Texas M.D. Anderson Cancer Center
Bibhusal Thapa, MBBS, MS, FCPS
Olivia Newton-John Cancer Research Institute, Australia
Phu Tran, MD
The University of California, Irvine
Marie Tzschaschel, MD
Ludwig-Maximilians University, Germany
Michelle Wilson, MBChB, FRACP
Princess Margaret Cancer Centre, Canada
Annie Wong, MBChB, FRACP
Peter MacCallum Cancer Centre, Australia
Kit Man Wong, MD
The University of Colorado
Melisa Wong, MD
The University of California, San Francisco
David Woods, PhD
New York University
Chi-Fu Yang, MD
Duke University
Ali Zahalka, BA, MSc
Albert Einstein College of Medicine

Supporters

Amgen
AstraZeneca
Celgene Corporation
Conquer Cancer Foundation
Gilead Sciences, Inc.
Janssen Oncology
Kidney Cancer Association
Lilly
Novartis Oncology
Jackson G. Simpson
Spectrum Pharmaceuticals
Takeda Oncology

This list reflects commitments as of April 27, 2016.

This grant receives support that may result in a report to the CMS Open Payments website under the Physician Payments Sunshine Act. The supporting companies are required to report the amount of the grant, the names of physicians who are awarded this grant, and the names of their institutions. This information may appear on the Open Payments website. More information about the Sunshine Act and CMS Open Payments program can be found here.